<DOC>
	<DOCNO>NCT02603744</DOCNO>
	<brief_summary>The goal study determine safety tolerability intra-ovarian injection adipose derive stromal cell woman premature ovarian failure study preliminary efficacy ADSCs intra ovarian injection ovarian function improvement .</brief_summary>
	<brief_title>Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation Women With Premature Ovarian Failure ( POF )</brief_title>
	<detailed_description>In study 9 patient diagnosis premature ovarian failure participate . The patient divide randomly 3 group , group contain 3 patient . First group receive 5 million ADSCs , second group receive 10 million cell third group receive 15millions ADSCs . Stem cell Transplantation method intraovarian injection ADSCs perform guidance transvaginal sonography . All patient follow 12 month cell injection evaluate adverse event .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Menopause , Premature</mesh_term>
	<criteria>female Age : 2039 FSH &gt; 20 liposuction contraindication thyroid dysfunction immune system disease past history cancer , chemotherapy , radiotherapy HIV+ , hepatitis B , C Severe endometriosis</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Premature ovarian failure adipose derive stromal cell intraovarian injection</keyword>
</DOC>